Immunomedics Inc (NASDAQ:IMMU) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | Director · Feb 26, 2020 – Oct 23, 2020 · Past |
| Jason M. Aryeh Other companies: Lifecore Biomedical, Inc. (Director · Since at least Aug 15, 2024); Orchestra BioMed Holdings, Inc. (Director · Since at least Jan 26, 2023); Anebulo Pharmaceuticals, Inc. (Board Member · Since at least May 6, 2021); Ligand Pharmaceuticals Incorporated (Director · Since at least May 30, 2007); Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 19, 2017 · Past); Novelion Therapeutics Inc (Director · Jun 4, 2012 – May 15, 2017 · Past); Myrexis Inc (Director · Oct 19, 2011 – Jun 18, 2012 · Past); Vaxart, Inc. (Director · May 18, 2007 – May 25, 2011 · Past) | Director · Jan 8, 2017 – Jan 8, 2017 · Past |
| Peter P Pfreundschuh Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past) | Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past |
| Scott A Canute Other companies: Oncorus Inc (Director · Dec 11, 2020 – Jun 23, 2022 · Past); Flexion Therapeutics Inc (Director · Jun 20, 2018 – Nov 19, 2021 · Past); Akebia Therapeutics, Inc. (Director · Jun 14, 2018 – Jun 6, 2019 · Past); Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past); Outlook Therapeutics, Inc. (Director · Oct 26, 2017 – Oct 26, 2017 · Past) | Director · Apr 2, 2018 – Oct 23, 2020 · Past |
| Robert Forrester Other companies: Verastem, Inc. (President and CEO, Director · Jan 26, 2012 – Jan 3, 2019 · Past); Myrexis Inc (Director · Nov 11, 2010 – Dec 8, 2011 · Past); EPIRUS Biopharmaceuticals Inc (EVP and COO, Director · May 14, 2007 – Dec 21, 2009 · Past) | Director · Jan 8, 2017 – Jan 8, 2017 · Past |
| Behzad Aghazadeh Other companies: Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Whitehawk Therapeutics, Inc. (Director · Since at least Aug 26, 2021) | Director · Oct 23, 2020 – Oct 23, 2020 · Past |
| Bryan Ball Other companies: Whitehawk Therapeutics, Inc. (Chief Technical Operations Officer · Since at least Apr 23, 2024); Intercept Pharmaceuticals Inc (Chief Qual. Officer & SVP Ops. · Jan 11, 2021 – Jul 11, 2022 · Past) | Chief Quality Officer · Mar 5, 2019 – Oct 23, 2020 · Past |
| Michael Garone Other companies: Adaptimmune Therapeutics PLC (Interim CFO · Oct 1, 2019 – Oct 1, 2019 · Past); Emisphere Technologies Inc (CFO · Mar 12, 2009 – Jan 14, 2016 · Past) | Chief Financial Officer · Jun 27, 2016 – Jul 3, 2017 · Past |
| Lorettta M Itri Other companies: Whitehawk Therapeutics, Inc. (CHIEF MEDICAL OFFICER · Oct 21, 2021 – Mar 1, 2024 · Past) | Chief Medical Officer · Oct 23, 2020 – Oct 23, 2020 · Past |
| Morris Rosenberg Other companies: Seagen Inc (EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past) | Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past |
| William Fricker Other companies: NRX Pharmaceuticals, Inc. (CFO & Treasurer · May 24, 2021 – May 24, 2021 · Past) | Principal Accounting Officer · Aug 23, 2018 – Oct 23, 2020 · Past |
| Gerard G Gorman | SVP, Fin. , and CFO · Jul 9, 2007 – Aug 16, 2013 · Past |
| Usama Malik | Chief Fin. & Business Officer · Apr 12, 2018 – Oct 23, 2020 · Past |